The Plasma Proteins Market in the United States – 2019 is one of our flagship reports providing a comprehensive review of the plasma proteins market in the most important global market. It provides estimated sales in units and dollars of all the therapeutic plasma-derived proteins by company, as well the sales of recombinant factors and non-factor products for the year 2019, and discusses trends in early 2020. It also includes extensive historical data on the market for forecasting purposes.

It has been published every year since 1974, and has historical data for growth comparisons. It also analyzes recent developments regarding plasma supply (US plasma collections totals and by company with history and pricing) and fractionation throughput and devlopment, product distribution and new therapeutic plasma proteins. The companies fractionating plasma and selling products in the United States are profiled.

The report is delivered electronically (Excel and pdf files).

 


 

THE PLASMA PROTEINS MARKET
IN THE UNITED STATES — 2019

 

TABLE OF CONTENTS

Page

 

1

 

14

42

58

88

88

100

125

147

200

210

214

216

227

240

 

 

 

 

EXECUTIVE SUMMARY

 

1) PLASMA COLLECTIONS

2) PLASMA FRACTIONATION

3) MARKET OVERVIEW

4) IMMUNE GLOBULIN MARKET

4.1) HYPERIMMUNE GLOBULINS

4.2) IVIG & SCIG MARKETS

5) ALBUMIN MARKET

6) HEMOPHILIA CARE MARKET

7) ALPHA-1 ANTITRYPSIN MARKET (AAT)

8) C-1 ESTERASE INHIBITOR MARKET (C1-INH)

9) ANTITHROMBIN III AND PROTEIN C MARKETS

10) FIBRIN SEALANT AND BIOSURGERY MARKET

11) DISTRIBUTION OF PLASMA PRODUCTS

12) PROFILES OF THE MAJOR COMPANIES